Hopwood, D.A., How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?. Mol Microbiol 63 (2007), 937–940.
D'Costa, V.M., McGrann, K.M., Hughes, D.W., Wright, G.D., Sampling the antibiotic resistome. Science 311 (2006), 374–377 Study showing that all soil-dwelling actinobacteria are multi-drug resistant and that they are a reservoir of resistance determinants for future antibiotics.
Cundliffe, E., Demain, A.L., Avoidance of suicide in antibiotic-producing microbes. J Ind Microbiol Biotechnol 37 (2010), 643–672.
Davies, J., Davies, D., Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev MMBR 74 (2010), 417–433.
Mak, S., Xu, Y., Nodwell, J.R., The expression of antibiotic resistance genes in antibiotic-producing bacteria. Mol Microbiol 93 (2014), 391–402 Overview on the regulatory mechanisms that couple resistance to antibiotic biosynthesis.
Surette, M.D., Wright, G.D., Lessons from the environmental antibiotic resistome. Annu Rev Microbiol 71 (2017), 309–329.
D'Costa, V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W.L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. Antibiotic resistance is ancient. Nature 477 (2011), 457–461.
Perry, J., Waglechner, N., Wright, G., The prehistory of antibiotic resistance. Cold Spring Harb Perspect Med, 2016, 6 Opinion/review article that explores the ancient nature of antibiotic resistance.
Forsberg, K.J., Reyes, A., Wang, B., Selleck, E.M., Sommer, M.O.A., Dantas, G., The shared antibiotic resistome of soil bacteria and human pathogens. Science 337 (2012), 1107–1111.
Galm, U., Hager, M.H., Van Lanen, S.G., Ju, J., Thorson, J.S., Shen, B., Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem Rev 105 (2005), 739–758 Exhaustive review on the history, modes of action, and resistance mechanisms — both in the producing organisms and in tumor cells — of bleomycins, mitomycin, and enediynes.
Gatignol, A., Durand, H., Tiraby, G., Bleomycin resistance conferred by a drug-binding protein. FEBS Lett 230 (1988), 171–175 First report suggesting drug sequestration as self-protection mechanism to bleomycins.
Rudolf, J.D., Bigelow, L., Chang, C., Cuff, M.E., Lohman, J.R., Chang, C.-Y., Ma, M., Yang, D., Clancy, S., Babnigg, G., et al. Crystal structure of the zorbamycin-binding protein ZbmA, the primary self-resistance element in Streptomyces flavoviridis ATCC21892. Biochemistry (Mosc) 54 (2015), 6842–6851.
Dumas, P., Bergdoll, M., Cagnon, C., Masson, J.M., Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering. EMBO J 13 (1994), 2483–2492 First elucidation of the crystal structure of sequestering proteins of the bleomycin-family of glycopeptide antitumor antibiotics.
Sugiyama, M., Kumagai, T., Hayashida, M., Maruyama, M., Matoba, Y., The 1.6-A crystal structure of the copper(II)-bound bleomycin complexed with the bleomycin-binding protein from bleomycin-producing Streptomyces verticillus. J Biol Chem 277 (2002), 2311–2320.
Kawano, Y., Kumagai, T., Muta, K., Matoba, Y., Davies, J., Sugiyama, M., The 1.5 A crystal structure of a bleomycin resistance determinant from bleomycin-producing Streptomyces verticillus. J Mol Biol 295 (2000), 915–925.
Martin, T.W., Dauter, Z., Devedjiev, Y., Sheffield, P., Jelen, F., He, M., Sherman, D.H., Otlewski, J., Derewenda, Z.S., Derewenda, U., Molecular basis of mitomycin C resistance in Streptomyces: structure and function of the MRD protein. Structure 10 (2002), 933–942 Study showing that structurally and functionally unrelated metabolites such as bleomycins and mitomycin C are neutralized by structurally related proteins.
Lombó F., Velasco, A., Castro, A., de la Calle, F., Braña, A.F., Sánchez-Puelles, J.M., Méndez, C., Salas, J.A., Deciphering the biosynthesis pathway of the antitumor thiocoraline from a marine actinomycete and its expression in two Streptomyces species. Chembiochem Eur J Chem Biol 7 (2006), 366–376.
Sheldon, P.J., Mao, Y., He, M., Sherman, D.H., Mitomycin resistance in Streptomyces lavendulae includes a novel drug-binding-protein-dependent export system. J Bacteriol 181 (1999), 2507–2512.
Biswas, T., Zolova, O.E., Lombó F., de la Calle, F., Salas, J.A., Tsodikov, O.V., Garneau-Tsodikova, S., A new scaffold of an old protein fold ensures binding to the bisintercalator thiocoraline. J Mol Biol 397 (2010), 495–507 Unique mechanism of resistance for quinoxalines involving a protein that is homologous to bleomycin-sequestering proteins.
Foulke-Abel, J., Kelly, G.T., Zhang, H., Watanabe, C.M.H., Characterization of AziR, a resistance protein of the DNA cross-linking agent azinomycin B. Mol Biosyst 7 (2011), 2563–2570 Unique case of an intracellular drug-binding protein that is structurally unrelated to bleomycin-sequestering proteins.
Danshiitsoodol, N., de Pinho, C.A., Matoba, Y., Kumagai, T., Sugiyama, M., The mitomycin C (MMC)-binding protein from MMC-producing microorganisms protects from the lethal effect of bleomycin: crystallographic analysis to elucidate the binding mode of the antibiotic to the protein. J Mol Biol 360 (2006), 398–408.
Povirk, L.F., Goldberg, I.H., Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid. Biochemistry (Mosc) 19 (1980), 4773–4780.
Baker, J.R., Woolfson, D.N., Muskett, F.W., Stoneman, R.G., Urbaniak, M.D., Caddick, S., Protein-small molecule interactions in neocarzinostatin, the prototypical enediyne chromoprotein antibiotic. Chembiochem Eur J Chem Biol 8 (2007), 704–717 Review of enediyne chromoproteins and description of applications of apoproteins.
Thorson, J.S., Shen, B., Whitwam, R.E., Liu, W., Li, Y., Ahlert, J., Enediyne biosynthesis and self-resistance: a progress report. Bioorg Chem 2 (1999), 172–188.
Sakata, N., Ikeno, S., Hori, M., Hamada, M., Otani, T., Cloning and nucleotide sequencing of the antitumor antibiotic C-1027 apoprotein gene. Biosci Biotechnol Biochem 56 (1992), 1592–1595.
Sakata, N., Kanbe, T., Tanabe, M., Hayashi, H., Hori, M., Hotta, K., Hamada, M., Nucleotide sequence of the macromomycin apoprotein gene and its expression in Streptomyces macromomyceticus. J Antibiot (Tokyo) 42 (1989), 1704–1712.
Hang, V.T.T., Kim, T.S., Oh, T.-J., Sohng, J.K., Influence of apoproteins for enediyne production. Biotechnol Bioprocess Eng 16 (2011), 462–469.
Cui, Z., Wang, L., Wang, S., Li, G., Hong, B., Disruption of cagA, the apoprotein gene of chromoprotein antibiotic C-1027, eliminates holo-antibiotic production, but not the cytotoxic chromophore. FEMS Microbiol Lett 301 (2009), 57–68.
Dubey, R., Kattusamy, K., Dharmalingam, K., Prasad, R., Daunorubicin forms a specific complex with a secreted serine protease of Streptomyces peucetius. World J Microbiol Biotechnol 30 (2014), 253–261.
Dubey, R., Prasad, R., Biophysical characterization of in vitro bound Streptomyces peucetius daunorubicin-serine protease complex. Int J Biol Macromol 64 (2014), 111–114.
Guilfoile, P.G., Hutchinson, C.R., A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. Proc Natl Acad Sci U S A 88 (1991), 8553–8557.
Gandlur, S.M., Wei, L., Levine, J., Russell, J., Kaur, P., Membrane topology of the DrrB protein of the doxorubicin transporter of Streptomyces peucetius. J Biol Chem 279 (2004), 27799–27806.
Li, W., Sharma, M., Kaur, P., The DrrAB efflux system of Streptomyces peucetius is a multidrug transporter of broad substrate specificity. J Biol Chem 289 (2014), 12633–12646.
Malla, S., Niraula, N.P., Liou, K., Sohng, J.K., Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. Microbiol Res 165 (2010), 259–267.
Fernández, E., Lombó F., Méndez, C., Salas, J.A., An ABC transporter is essential for resistance to the antitumor agent mithramycin in the producer Streptomyces argillaceus. Mol Gen Genet MGG 251 (1996), 692–698.
Menéndez, N., Braña, A.F., Salas, J.A., Méndez, C., Involvement of a chromomycin ABC transporter system in secretion of a deacetylated precursor during chromomycin biosynthesis. Microbiol Read Engl 153 (2007), 3061–3070 Efflux system exporting a weakly toxic precursor and not the final highly toxic metabolite.
Menéndez, N., Nur-E-Alam, M., Braña, A.F., Rohr, J., Salas, J.A., Méndez, C., Tailoring modification of deoxysugars during biosynthesis of the antitumour drug chromomycin A by Streptomyces griseus ssp. griseus. Mol Microbiol 53 (2004), 903–915.
Sheldon, P.J., Johnson, D.A., August, P.R., Liu, H.W., Sherman, D.H., Characterization of a mitomycin-binding drug resistance mechanism from the producing organism, Streptomyces lavendulae. J Bacteriol 179 (1997), 1796–1804.
Ostash, I., Ostash, B., Walker, S., Fedorenko, V., Proton-dependent transporter gene lndJ confers resistance to landomycin E in Streptomyces globisporus. Genetika 43 (2007), 1032–1037.
Liu, W., Shen, B., Genes for production of the enediyne antitumor antibiotic C-1027 in Streptomyces globisporus are clustered with the cagA gene that encodes the C-1027 apoprotein. Antimicrob Agents Chemother 44 (2000), 382–392.
Coughlin, J.M., Rudolf, J.D., Wendt-Pienkowski, E., Wang, L., Unsin, C., Galm, U., Yang, D., Tao, M., Shen, B., BlmB and TlmB provide resistance to the bleomycin family of antitumor antibiotics by N-acetylating metal-free bleomycin, tallysomycin, phleomycin, and zorbamycin. Biochemistry (Mosc) 53 (2014), 6901–6909 Study evidencing acetylation of bleomycins as drug modification mechanism of resistance to DNA-damaging agents.
August, P.R., Flickinger, M.C., Sherman, D.H., Cloning and analysis of a locus (mcr) involved in mitomycin C resistance in Streptomyces lavendulae. J Bacteriol 176 (1994), 4448–4454.
August, P.R., Rahn, J.A., Flickinger, M.C., Sherman, D.H., Inducible synthesis of the mitomycin C resistance gene product (MCRA) from Streptomyces lavendulae. Gene 175 (1996), 261–267.
Johnson, D.A., August, P.R., Shackleton, C., Liu, H., Sherman, D.H., Microbial resistance to mitomycins involves a redox relay mechanism. J Am Chem Soc 119 (1997), 2576–2577 Study evidencing modification of Mitomycin as unique drug oxidation mechanism of resistance to DNA-damaging agents.
Biggins, J.B., Onwueme, K.C., Thorson, J.S., Resistance to enediyne antitumor antibiotics by CalC self-sacrifice. Science 301 (2003), 1537–1541 Demonstration of the existence of a new resistance mechanism to antitumor antibiotics called self-sacrifice.
Singh, S., Hager, M.H., Zhang, C., Griffith, B.R., Lee, M.S., Hallenga, K., Markley, J.L., Thorson, J.S., Structural insight into the self-sacrifice mechanism of enediyne resistance. ACS Chem Biol 1 (2006), 451–460 3D structures of the self-sacrifice CalC protein in complex with calicheamicin and demonstration of the oxidative proteolysis-based resistance mechanism.
Elshahawi, S.I., Ramelot, T.A., Seetharaman, J., Chen, J., Singh, S., Yang, Y., Pederson, K., Kharel, M.K., Xiao, R., Lew, S., et al. Structure-guided functional characterization of enediyne self-sacrifice resistance proteins, CalU16 and CalU19. ACS Chem Biol 9 (2014), 2347–2358.
Furuya, K., Hutchinson, C.R., The DrrC protein of Streptomyces peucetius, a UvrA-like protein, is a DNA-binding protein whose gene is induced by daunorubicin. FEMS Microbiol Lett 168 (1998), 243–249 Study first suggesting DNA repair mediated by UvrA-like proteins as mechanism of drug self-resistance.
Prija, F., Prasad, R., DrrC protein of Streptomyces peucetius removes daunorubicin from intercalated dnrI promoter. Microbiol Res 202 (2017), 30–35.
Lomovskaya, N., Hong, S.K., Kim, S.U., Fonstein, L., Furuya, K., Hutchinson, R.C., The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production. J Bacteriol 178 (1996), 3238–3245.
Garcia-Bernardo, J., Braña, A.F., Méndez, C., Salas, J.A., Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus. FEMS Microbiol Lett 186 (2000), 61–65.
Wang, S., Liu, K., Xiao, L., Yang, L., Li, H., Zhang, F., Lei, L., Li, S., Feng, X., Li, A., et al. Characterization of a novel DNA glycosylase from S. sahachiroi involved in the reduction and repair of azinomycin B induced DNA damage. Nucleic Acids Res 44 (2016), 187–197.
Mullins, E.A., Warren, G.M., Bradley, N.P., Eichman, B.F., Structure of a DNA glycosylase that unhooks interstrand cross-links. Proc Natl Acad Sci U S A 114 (2017), 4400–4405.
Sánchez, C., Butovich, I.A., Braña, A.F., Rohr, J., Méndez, C., Salas, J.A., The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives. Chem Biol 9 (2002), 519–531.
Crnovčić I., Rückert, C., Semsary, S., Lang, M., Kalinowski, J., Keller, U., Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C. Adv Appl Bioinforma Chem AABC 10 (2017), 29–46.
Takano, E., Gramajo, H.C., Strauch, E., Andres, N., White, J., Bibb, M.J., Transcriptional regulation of the redD transcriptional activator gene accounts for growth-phase-dependent production of the antibiotic undecylprodigiosin in Streptomyces coelicolor A3(2). Mol Microbiol 6 (1992), 2797–2804.
Tenconi, E., Traxler, M., Hoebreck, C., Wezel, G.P., van Rigali, S., Prodiginine production in Streptomyces coelicolor correlates temporally and spatially to programmed cell death. bioRxiv, 2018, 10.1101/240689 First study hypothesizing that self-made DNA-damaging metabolites could be part of the programmed cell death process of the producing organism.
Dortet, L., Nordmann, P., Poirel, L., Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother 56 (2012), 1693–1697.
Dortet, L., Girlich, D., Virlouvet, A.-L., Poirel, L., Nordmann, P., Iorga, B.I., Naas, T., Characterization of BRPMBL, the bleomycin resistance protein associated with the carbapenemase NDM. Antimicrob Agents Chemother, 61, 2017 pii:e02413-16.
